Stay updated on PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial

Sign up to get notified when there's something new on the PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.0%
    Check dated 2025-06-05T11:20:15.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    0.5%
    Check dated 2025-05-29T06:07:59.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page has undergone significant changes with the removal of several key research articles and their corresponding citations, which may impact the credibility and comprehensiveness of the content related to cancer research.
    Difference
    0.7%
    Check dated 2025-05-22T03:44:39.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page has removed a citation regarding a study on tumor-associated B7-H1 and its role in T-cell apoptosis, including an erratum reference.
    Difference
    0.1%
    Check dated 2025-05-14T23:28:45.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page has removed a citation regarding improved survival with ipilimumab in patients with metastatic melanoma, which is a significant change in core content.
    Difference
    0.1%
    Check dated 2025-05-07T19:34:57.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-04-30T14:22:54.000Z thumbnail image

Stay in the know with updates to PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial page.